Robustness of Massively Parallel Sequencing Platforms

Resource type
Date created
2015
Authors/Contributors
Abstract
The improvements in high throughput sequencing technologies (HTS) made clinical sequencing projects such as ClinSeq and Genomics England feasible. Although there are significant improvements in accuracy and reproducibility of HTS based analyses, the usability of these types of data for diagnostic and prognostic applications necessitates a near perfect data generation. To assess the usability of a widely used HTS platform for accurate and reproducible clinical applications in terms of robustness, we generated whole genome shotgun (WGS) sequence data from the genomes of two human individuals in two different genome sequencing centers. After analyzing the data to characterize SNPs and indels using the same tools (BWA, SAMtools, and GATK), we observed significant number of discrepancies in the call sets. As expected, the most of the disagreements between the call sets were found within genomic regions containing common repeats and segmental duplications, albeit only a small fraction of the discordant variants were within the exons and other functionally relevant regions such as promoters. We conclude that although HTS platforms are sufficiently powerful for providing data for first-pass clinical tests, the variant predictions still need to be confirmed using orthogonal methods before using in clinical applications.
Document
Published as
Kavak P, Yüksel B, Aksu S, Kulekci MO, Güngör T, Hach F, et al. (2015) Robustness of Massively Parallel Sequencing Platforms. PLoS ONE 10(9): e0138259. doi:10.1371/journal.pone.0138259
Publication title
PLoS ONE
Document title
Robustness of Massively Parallel Sequencing Platforms
Date
2015
Volume
10
Issue
9
Publisher DOI
10.1371/journal.pone.0138259
Copyright statement
Copyright is held by the author(s).
Scholarly level
Peer reviewed?
Yes
Language
Member of collection
Attachment Size
journal.pone_.0138259.pdf 481.78 KB